期刊文献+

两种乙型肝炎病毒核酸定量试剂对315例样本检测结果的比较 被引量:5

Test results of 315 serum samples by two reagents for quantification of hepatitis B virus DNA
原文传递
导出
摘要 目的采用国内和国外乙型肝炎病毒核酸(HBV DNA)定量检测试剂盒检测315份血清样本,比较两种试剂检测能力的差异。方法采用Abbott Architect i2000化学发光检测试剂盒检测315份样本的乙型肝炎血清学五项指标后,再用进口(简称"Roche试剂")及国产(简称"国产试剂")乙型肝炎病毒核酸定量试剂盒进行复检,比较两种试剂检测结果的一致性。结果两种试剂定性结果阳性符合率为60.6%(134/221),阴性符合率为100%(94/94),总符合率为72.4%,检测结果差异有统计学意义(P<0.01);无论对HBsAg阳性或阴性样本,Roche试剂的阳性检出率均明显高于国产试剂(P均<0.01),灵敏度为导致二者检测结果产生差异的主要原因;定量结果相关性和一致性分析表明,两种试剂定量检测结果有较好的一致性。结论不同试剂盒检测HBV DNA灵敏度差异较大,本实验国产HBV DNA定量试剂盒灵敏度较低,质量有待提高。 Objective To test 315 serum samples by domestic and imported reagents for quantification of hepatitis B virus(HBV) DNA and compare the test abilities of two reagents.Methods A total of 315 serum samples were determined for five serological indexes of hepatitis B by using Abbott Architect i2000 chemoluminescent kit,then the HBV DNA results obtained by imported(Roche)and domestic kits were compared.Results The positive and negative coincidence rates of Roche and domestic reagents were 60.6%(134 / 221)and 100%(94 / 94),respectively,while the total coincidence rate was 72.4%,indicating a significant difference(P 0.01).The positive rates of both HBsAg-positive and-negative samples confirmed by Roche reagent were significantly higher than those by domestic reagent(both P 0.01),which was mainly due to the sensitivities of the two reagents.However,the quantification results by the two reagents showed high consistence.Conclusion Compared with imported reagent,the domestic HBV DNA quantification reagent used in this study showed low sensitivity,of which the quality should be further improved.
出处 《中国生物制品学杂志》 CAS CSCD 2013年第8期1151-1153,1160,共4页 Chinese Journal of Biologicals
基金 十一五专项乙型肝炎质量控制及评价研究(2009ZX-10006-802)
关键词 肝炎病毒 乙型 核酸 荧光定量 Hepatitis virus B Nucleic acid Fluorescent quantification
  • 相关文献

参考文献10

  • 1Sch midt M, Nubling CM, Seheiblauer H, et al. Anti-HBc screening of blood donors: a comparison of nine anti-HBe tests [J]. Vox Sang, 2006, 91 (3): 237-243.
  • 2Liang X, Bi S, Yang W, et al. Epidemiologieal serosurvey of hepatitis B in China-declining HBV prevalence due 1o hepatitis B vaccination [J]. Vaccine, 2009, 27 (47): 6550- 6557.
  • 3WHO. Weekly epidemiological record,Hepatitis B vaccines [OL/R ] . http ://www.who.inffwer2009,84,405-420.
  • 4王良华,叶贤林,尚桂芳,周雄伟,周晓露.免疫筛查阴性献血者血样病毒核酸检测的研究[J].中国输血杂志,2005,18(4):286-289. 被引量:75
  • 5Heermann KH, Gerlieh WH, Chudy M, et al. Quan-litative detection of hepatitis B virus DNA in two interna-tional reference plasma preparations [J]. J Clin Mierobiol, 1999, 37 ( 1 ) : 68-73.
  • 6Mosley JW, Steven CE, Aach RD, et cd. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients [J]. Transfusion, 1995, 35 (1): 5-12.
  • 7蒋素贞,鲁凤民,庄辉.慢性乙型肝炎病毒DNA定量检测的临床意义[J].中华检验医学杂志,2012,35(2):117-121. 被引量:26
  • 8Brezillon N, Brunelle MN, Massinet H, et ol. Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb- uPA / SCID mice[J]. PLoS One, 2011, 6 (12): e25096.
  • 9Ozaras R, Tabak F, Tahan V, et al. Correlation of quantitative assay of HBsAg and HBV DNA levels during chronic HBV treatment [ J ]. Dig Dis Sci, 2008, 53 ( 11 ) : 2995-2998.
  • 10Hochberger S, Althof D, Gallegos De Schrott R,et ol. Fully automated quantitation of hepatitis B virus (HBV) DNA in human plasma by the COBAS AmpliPrep / COBAS TaqMan system [J]. J Clin Virol, 2006, 35(4): 373-380.

二级参考文献15

  • 1李美忠,王敏,乐晓华,王火生,陈心春,徐六妹,周伯平.四种HBV DNA荧光定量PCR试剂比较及其结果分析[J].中华实验和临床感染病杂志(电子版),2008,2(1):7-12. 被引量:17
  • 2Ganarda JL, Dragon E. Blood screening by nucleic acid amplification technology: current issues, future challenges. Mol Diag,2000,5(1) :11.
  • 3Busch MP, Kleinman SH, Jackson B, et al. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases. Transfusion, 2000,40(2) : 143.
  • 4Busch MP. HIV, HBV, HCV: new developments related to transfusion safety. Vox Sang, 2000,78(Suppl. 2) :253.
  • 5Carman WF, Jacyna MR, Hadziyannis S, et al. Mutation preventing formation of hepatitis antigen in patients with chronic hepatitis. Lancet, 1989,334:588.
  • 6Carman WF, Zanetti AR, Karayiannis P, et al. Vaccine-induce escape mutant of hepatitis B virus. Lancet, 1990,336,325.
  • 7Zuckerman AJ, Harrison TJ, Oon CJ. Mutants in the S region of hepatitis B virus. Lancet, 1994,343:737.
  • 8Cacciola I, Pollicino T, Squadrito G, et al. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med,1999, 341(1):22.
  • 9Dow BC, Peterkin MA, Green RH, et al. Hepattis B virus transmission by blood donation negative for hetitis B surface antigen, antibody to HBsAg, antibody to hepatitis B core antigen and HBV DNA. Vox Sang,2001,81(3):140.
  • 10LU Feng-min ZHUANG Hui.Management of hepatitis B in China[J].Chinese Medical Journal,2009(1):3-4. 被引量:661

共引文献99

同被引文献24

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部